Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
2017-12-08 07:53來源：原版作者：Liu Z
A limitation of positive selection strategies to enrich for circulating tumor cells (CTCs) is that there might be CTCs with insufficient expression of the surface target marker which may be missed by the procedure. We optimized a method for enrichment, subsequent detection and characterization of CTCs based on depletion of the leukocyte fraction.
The 2-step protocol was developed for processing 20 mL blood and based on red blood cell lysis followed by leukocyte depletion. The remaining material was stained with the epithelial markers EpCAM and cytokeratin (CK) 7/8 or for the melanoma marker HMW-MAA/MCSP. CTCs were detected by flow cytometry. CTCs enriched from blood of patients with carcinoma were defined as EpCAM+CK+CD45-. CTCs enriched from blood of patients with melanoma were defined as MCSP+CD45-. One-hundred-sixteen consecutive blood samples from 70 patients with metastatic carcinomas (n = 48) or metastatic melanoma (n = 22) were analyzed.
CTCs were detected in 47 of 84 blood samples (56%) drawn from carcinoma patients, and in 17 of 32 samples (53%) from melanoma patients. CD45-EpCAM-CK+ was detected in pleural effusion specimens, as well as in peripheral blood samples of patients with NSCLC. EpCAM-CK+ cells have been successfully cultured and passaged longer than six months suggesting their neoplastic origin. This was confirmed by CGH. By defining CTCs in carcinoma patients as CD45-CK+ and/or EpCAM+, the detection rate increased to 73% (61/84).
Enriching CTCs using CD45 depletion allowed for detection of epithelial cancer cells not displaying the classical phenotype. This potentially leads to a more accurate estimation of the number of CTCs. If detection of CTCs without a classical epithelial phenotype has clinical relevance need to be determined.
- > 《醫學拾萃》2019年12月刊：真空采血管對凝血試驗的影響
- > 《醫學拾萃》2019年11月刊：靜脈血和末梢血在臨床檢測項目中的差別應用（續）
- > 《醫學拾萃》2019年10月刊：靜脈血和末梢血在臨床檢測項目中的差別應用
- > 《醫學拾萃》2019年9月刊：腎素-血管緊張素-醛固酮系統（RAAS）及其在相關疾病中的調節作用
- > 《醫學拾萃》2019年8月刊：樣本收集和液體活檢對胰腺癌早期診斷的意義
- > 《醫學拾萃》2019年7月刊：全血 RNA 管的應用以及基因表達譜
- > 《醫學拾萃》2019年6月刊：血小板釋放
- > 《醫學拾萃》2019年5月刊：臨檢樣本溶血的原因、鑒定以及對臨檢指標的影響
- > 《醫學拾萃》2019年4月刊：對臨檢樣本分析前誤差的來源和分布的統計
- > 《醫學拾萃》2019年3月刊：巨噬細胞與腫瘤細胞的多重互動及其臨床意義